Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|February 22, 2020
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patientsConstance Chapuis-Biron, Anne Bourrier, Maria Nachury, et al.
Digestive Diseases and Sciences|March 5, 2022
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS StudyLucas Guillo, Aurélien Amiot, Mélanie Serrero, et al.
Clinical and Translational Gastroenterology|December 8, 2025
IMPACT OF ENDOMETRIOSIS ON THE PROGRESSION OF INFLAMMATORY BOWEL DISEASES: A MULTICENTER RETROSPECTIVE STUDYLucas Guillo, Oumaya El Oumami, Philippe Seksik, et al.
Gastroenterology|February 26, 2026
Uncovering the dynamics of mucosa-associated microbiota in post-operative recurrence of Crohn's diseaseLéonard Dubois, Alexandre Chaussard, Philippe Seksik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2019
Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's DiseaseEelco C Brand, Sjoerd G Elias, Itta M Minderhoud, et al.
Clinical and Translational Gastroenterology|July 31, 2023
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube DigestifLucas Guillo, Guillaume Savoye, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2020
Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAIDDoriane Broussard, Pauline Rivière, Joelle Bonnet, et al.
The American Journal of Gastroenterology|December 14, 2016
Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND GroupMathurin Fumery, Philippe Seksik, Claire Auzolle, et al.
Inflammatory Bowel Diseases|February 27, 2016
Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent MalignancyFlorian Poullenot, Philippe Seksik, Laurent Beaugerie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015
Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic StricturesMathurin Fumery, Guillaume Pineton de Chambrun, Carmen Stefanescu, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|February 22, 2020
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patientsConstance Chapuis-Biron, Anne Bourrier, Maria Nachury, et al.
Digestive Diseases and Sciences|March 5, 2022
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS StudyLucas Guillo, Aurélien Amiot, Mélanie Serrero, et al.
Clinical and Translational Gastroenterology|December 8, 2025
IMPACT OF ENDOMETRIOSIS ON THE PROGRESSION OF INFLAMMATORY BOWEL DISEASES: A MULTICENTER RETROSPECTIVE STUDYLucas Guillo, Oumaya El Oumami, Philippe Seksik, et al.
Gastroenterology|February 26, 2026
Uncovering the dynamics of mucosa-associated microbiota in post-operative recurrence of Crohn's diseaseLéonard Dubois, Alexandre Chaussard, Philippe Seksik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2019
Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's DiseaseEelco C Brand, Sjoerd G Elias, Itta M Minderhoud, et al.
Clinical and Translational Gastroenterology|July 31, 2023
Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube DigestifLucas Guillo, Guillaume Savoye, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2020
Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAIDDoriane Broussard, Pauline Rivière, Joelle Bonnet, et al.
The American Journal of Gastroenterology|December 14, 2016
Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND GroupMathurin Fumery, Philippe Seksik, Claire Auzolle, et al.
Inflammatory Bowel Diseases|February 27, 2016
Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent MalignancyFlorian Poullenot, Philippe Seksik, Laurent Beaugerie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015
Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic StricturesMathurin Fumery, Guillaume Pineton de Chambrun, Carmen Stefanescu, et al.
Pageof 17